SAPA-NE 2026 Biotech Startup Roadshow

About this event

Founders pitch. Investors and industry leaders judge. Boston connects.

Saturday, November 7, 2026 | 12:30 – 5:30 PM ET | In Person Arnold & Porter, 500 Boylston St, 20th Floor, Boston, MA 02116

About This Event

SAPA-NE invites you to an afternoon with some of New England's most promising biotech startups. Founders will present their science and plans to a panel of venture investors and industry leaders, and then take live questions from the judges.

It's a chance to see new drug discovery platforms early, hear how experienced investors evaluate a company, and meet founders, investors and peers from across the Boston biotech community.

Why Attend

• See new science early. AI-enabled drug discovery, ALS and neurodegeneration, AI for human physiology, RNA therapeutics, and oral peptides

• Learn how investors think. Judges' live Q&A shows what VCs and pharma look for in a startup

• Meet the ecosystem. Network with founders, investors, and industry professionals in a small-room setting

Who Should Attend

Founders and aspiring entrepreneurs, investors, business development and corporate strategy professionals, and scientists curious about the startup path.

Presenting Startups

Bin Chen, PhD , Founder, Bronto Therapeutics Transcriptome-based AI-enabled drug discovery

Chengliang Zhang, PhD , Co-founder, Alteron Therapeutics Pharmacological inhibition of TDP-43 activity as a paradigm-shifting therapeutic strategy for ALS, AD and other neurodegenerative disorders

Wei Jin, PhD , CSO, InTimeHealth Building the AI foundation for longitudinal human physiology

Jason Zhang, PhD , Founder, Zipcode Bio Programming Medicine: AI-first RNA therapeutics

John Su, PhD , Founder & CEO, STD Lab Oral cyclic peptide drug development platform

Judges & Mentors

Jerry Fan, CPA : Director of Strategic Finance, Vertex

Claire Jin : Vice President, J.P. Morgan Life Sciences & Healthcare

Leo Qian, PhD : Founder & CEO, stealth startup; Co-founder, Entrada Therapeutics

Gary R. Schall : Partner, Arnold & Porter

Kate Zhang, PhD : Venture Partner, Tailwinds Ventures; former CSO, Hopewell Therapeutics

Registration

Seating is limited to about 25 guests. Registration requires approval.

Please submit a request to attend. We review every request and will email you a confirmation if you are approved and a seat is available. Only confirmed guests can be admitted, and building security will check names at the lobby, so please register with the name on your photo ID.

Questions?

Venue courtesy of Arnold & Porter . Thank you for hosting us.

Building Bridges. Advancing Science. Improving Lives.